Capsaicin
From Anvita Health Wiki
Contents |
Introduction
- Tradename: Zostrix, Qutenza.
Indications
- temporary relief of pain due to:
- rheumatoid arthritis
- osteoarthritis
- neuralgia ( diabetic, shingles, post Herpetic neuralgia)
- musculoskeletal pain [4]
Dosage
- Cream: 0.025%, 0.075%. 45 g
- Transdermal patch Qutenza: 8%
Adverse-effects
- burning of skin & mucous membranes
- stinging
- erythema
Mechanism-of-action
- depletion of substance P
Notes
- Qutenza cost: $700/treatment (2010)
More General Terms
Internet Database
PubChem: 2548
PubChem: 1548943
References
- The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- Geriatrics Review Syllabus, American Geriatrics Society, 5th edition, 2002-2004
- Journal Watch 24(11):91, 2004 Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ. 2004 Apr 24;328(7446):991. Epub 2004 Mar 19. Review. <PubMed> PMID: [1] <Internet> [2]
- FDA NEWS RELEASE, Nov. 17, 2009 FDA Approves New Drug Treatment for Long-Term Pain Relief after Shingles Attacks [3]
- Qutenza prescribing information [4] - Prescriber's Letter 17(5): 2010 COMMENTARY: Qutenza: A High Dose Capsaicin Patch GUIDELINES: Treatment of Postherpetic Neuralgia (QSS-ANN, 2004) GUIDELINES: Prevention of Herpes Zoster (ACIP, 2008) Detail-Document#: [5] (subscription needed) [6]
